Aditya Birla Sun Life AMC shares jumped up to 4.75% to a 52-week high of Rs 1,098.90, fueled by bullish notes from brokerages and strong Q4 performance. Motilal Oswal reiterated a BUY rating, citing positive momentum. The rally raises the question many investors ask: do fundamentals justify chasing the move, or is caution warranted?
Dr Reddy’s shares dropped about 2% after Goldman Sachs downgraded the stock and Citigroup turned cautious. Brokerages pointed to limited growth visibility, pipeline concerns, and valuation risks, alongside generics pricing pressure. Citi also flagged muted near-term opportunities in semaglutide, prompting analysts to warn that downside risks may persist despite earlier optimism.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
